OTTO KUCHEL, M. D., Sc.D.; NGUYEN T. BUU, Ph.D.; JOLANTA GUTKOWSKA, Ph. D.; JACQUES GENEST, M.D., D.Sc
Supported by a grant from the Medical Research Council of Canada to a multidisciplinary group of hypertension.
▸Requests for reprints should be addressed to Otto Kuchel, M.D.; Clinical Research Institute, 110 Pine Avenue West; Montreal, Quebec, Canada H2W 1R7.
KUCHEL O., BUU N., GUTKOWSKA J., GENEST J.; Treatment of Severe Orthostatic Hypotension by Metoclopramide. Ann Intern Med. 1980;93:841-843. doi: 10.7326/0003-4819-93-6-841
Download citation file:
Published: Ann Intern Med. 1980;93(6):841-843.
The cardiovascular consequences of a deficient release of norepinephrine at nervous terminals are dependent on its balance with some vasodilator and natriuretic substances (bradykinin, some prostaglandins, and dopamine [for review see Reference I]) whose action is opposite that of norepinephrine. Treatment by substances that inhibit bradykinin and prostaglandin action or synthesis proved effective in many cases of orthostatic hypotension (2). We have reported (3) that in severe orthostatic hypotension with increased urinary dopamine excretion the condition has been considerably improved by treatment with carbidopa, a peripheral inhibitor of dopamine synthesis. The introduction of an assay for conjugated dopamine in plasma
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Infectious Disease, Nephrology, HIV, Hypertension.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only